Mirtazapine Tablet, Orally Disintegrating
Product Images NDC 55154-8335

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-8335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (E8d56e08 0450 4b5e 88c9 Ebb12725b263 00)

Label for Mirtazapine orally disintegrating tablets USP 15 mg, 6 unit dose tablets. The label includes instructions on contents, dosage, how to remove tablets, storage conditions, warnings, and distributor information. It states the product is for prescription use, not child resistant, and intended for institutional use only. Distributed by Cardinal Health 107, LLC.*

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical structure of Mirtazapine, showing its characteristic fused ring system and nitrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.